Haemonetics Vascade Vascular Closure System Introduced in Europe

August 29, 2023—Haemonetics Corporation announced the introduction of the company’s Vascade portfolio in Europe with the first commercial use of the Vascade MVP venous vascular closure system in Germany. The Vascade systems were subsequently released for use in Italy.

The Vascade system is designed for small-bore femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures.

The Vascade MVP system is designed for mid-bore, multiaccess femoral venous closure, generally used in electrophysiology procedures.

According to the company, the Vascade systems have been commercially available and widely used in the United States.

Haemonetics advised it is planning further expansion for the Vascade system portfolio in other markets outside the United States. The company recently announced the distribution of the Vascade MVP system in Japan via an exclusive agreement with Japan Lifeline Co. Ltd. A product launch is expected in Japan later this year.

In September 2022, the company announced it earned European MDR CE Mark certification for the Vascade vascular closure and Vascade MVP venous vascular closure systems for use in patients who have undergone catheter-based procedures with single or multiple access sites in one or both limbs.

Haemonetics stated that the Vascade devices include the company’s collapsible disc technology and a resorbable collagen patch to achieve hemostasis. The Vascade and Vascade MVP systems are designed to reach hemostasis faster with fewer complications on average compared to manual compression.

“First and foremost, the Vascade MVP system helps promote patient well-being,” commented Bogdan Muntean, MD, in the company’s press release. “There is a very short postprocedural bed rest, which can reduce back pain and the need for urinary catheters and create the possibility for same-day discharge.”

Dr. Muntean, who is Senior Physician of Cardiology and Medical Director of Electrophysiology at The Jewish Hospital in Berlin, Germany, continued, “From a handling perspective, the Vascade MVP device is logical to operate and has smooth control. During the product evaluation, we achieved hemostasis in the electrophysiology lab without the need of any further compressive bandages.”